Related Experiment Video
Updated: Mar 17, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
Douglas F Dluzen1, Aimee K Sutliff1, Gang Chen1
1National Institute on Aging, National Institutes of Health, Baltimore, Maryland (D.F.D.); Department of Pulmonary Medicine, Penn State University College of Medicine, Hershey, Pennsylvania (F.T.I.); and Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, Washington (A.K.S., G.C., C.W., P.L.).
Abstract:
The UDP-glucuronosyltransferase (UGT) 2B enzymes are important in the detoxification of a variety of endogenous and exogenous compounds, including many hormones, drugs, and carcinogens. Identifying novel mechanisms governing their expression is important in understanding patient-specific response to drugs and cancer risk factors. In silico prediction algorithm programs were used to screen for microRNAs (miRNAs) as potential regulators of UGT2B enzymes, with miR-216b-5p identified as a potential candidate. Luciferase data suggested the presence of a functional miR-216b-5p binding motif within the 3' untranslated regions of UGTs 2B7, 2B4, and 2B10. Overexpression of miR-216b-5p mimics significantly repressed UGT2B7 (P < 0.001) and UGT2B10 (P = 0.0018) mRNA levels in HuH-7 cells and UGT2B4 (P < 0.001) and UGT2B10 (P = 0.018) mRNA in Hep3B cells. UGT2B7 protein levels were repressed in both HuH-7 and Hep3B cells in the presence of increasing miR-216b-5p concentrations, corresponding with significant (P < 0.001 and P = 0.011, respectively) decreases in glucuronidation activity against the UGT2B7-specific substrate epirubicin. Inhibition of endogenous miR-216b-5p levels significantly increased UGT2B7 mRNA levels in HuH-7 (P = 0.021) and Hep3B (P = 0.0068) cells, and increased epirubicin glucuronidation by 85% (P = 0.057) and 50% (P = 0.012) for HuH-7 and Hep3B cells, respectively. UGT2B4 activity against codeine and UGT2B10 activity against nicotine were significantly decreased in both HuH-7 and Hep3B cells (P < 0.001 and P = 0.0048, and P = 0.017 and P = 0.043, respectively) after overexpression of miR-216b-5p mimic. This is the first evidence that miRNAs regulate UGT 2B7, 2B4, and 2B10 expression, and that miR-216b-5p regulation of UGT2B proteins may be important in regulating the metabolism of UGT2B substrates.
Insights
MicroRNAs regulate UDP-glucuronosyltransferase (UGT) 2B enzymes, crucial for drug and carcinogen detoxification. This study identifies miR-216b-5p as a key regulator impacting UGT2B7, UGT2B4, and UGT2B10 expression and activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- UDP-glucuronosyltransferase (UGT) 2B enzymes are critical for metabolizing endogenous and exogenous compounds, influencing drug response and cancer risk.
- Understanding the regulation of UGT2B enzymes is vital for personalized medicine and assessing carcinogen exposure.
- MicroRNAs (miRNAs) are emerging as key post-transcriptional regulators of gene expression.
Purpose of the Study:
- To identify and characterize microRNAs that regulate the expression of UGT2B enzymes.
- To investigate the functional role of miR-216b-5p in controlling UGT2B7, UGT2B4, and UGT2B10 expression and activity.
- To establish the significance of miRNA-mediated UGT2B regulation in cellular metabolism.
Main Methods:
- In silico screening to predict potential miRNA regulators of UGT2B enzymes.
- Luciferase assays to confirm miRNA binding sites in UGT 3' UTRs.
- Overexpression and inhibition studies of miR-216b-5p in HuH-7 and Hep3B cell lines.
- Quantitative analysis of UGT2B mRNA and protein levels.
- Measurement of UGT enzyme activity using specific substrates (epirubicin, codeine, nicotine).
Main Results:
- miR-216b-5p was identified as a potential regulator, with functional binding sites in UGT2B7, UGT2B4, and UGT2B10.
- Overexpression of miR-216b-5p significantly repressed UGT2B7, UGT2B4, and UGT2B10 mRNA and protein levels.
- miR-216b-5p overexpression led to decreased glucuronidation activity for UGT2B7 (epirubicin), UGT2B4 (codeine), and UGT2B10 (nicotine).
- Inhibition of endogenous miR-216b-5p increased UGT2B7 mRNA levels and epirubicin glucuronidation activity.
Conclusions:
- This study provides the first evidence that miRNAs regulate UGT2B7, UGT2B4, and UGT2B10 expression.
- miR-216b-5p acts as a negative regulator of UGT2B enzymes, impacting their metabolic functions.
- The miR-216b-5p-UGT2B interaction is a significant mechanism influencing the metabolism of UGT2B substrates and potentially patient drug responses.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Cell Specific Gene Expression

